CN Stock MarketDetailed Quotes

000919 Jinling Pharmaceutical

Watchlist
  • 6.26
  • -0.01-0.16%
Market Closed Jun 28 15:00 CST
3.94BMarket Cap39.62P/E (TTM)

Jinling Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
medical service1.35B48.29%
chemical968.43M34.76%
Traditional Chinese medicine406.05M14.58%
Other52.28M1.88%
API and pharmaceutical intermediates13.63M0.49%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Drug production and marketing1.39B49.83%
medical service1.35B48.29%
Other52.28M1.88%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
East China (six provinces and one city)2.6B93.22%
Central and Southwest regions (Henan, Hubei, Guangdong, Guangxi)129.81M4.66%
North China (Hebei, Beijing, Tianjin)21.92M0.79%
Northeast region (Liaoning, Jilin, Heilongjiang)16.23M0.58%
西北大区（山西、内蒙古、宁夏、陕西）11.36M0.41%
Xinjiang region5.54M0.20%
Overseas3.91M0.14%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg